SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-000622
Filing Date
2024-02-02
Accepted
2024-02-02 16:22:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6999
  Complete submission text file 0001950047-24-000622.txt   8699
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-51122 | Film No.: 24591795
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O EYEPOINT PHARMACEUTICALS, INC., 480 PLEASANT STREET, SUITE A210 WATERTOWN MA 02472
Business Address
Jones David Scott (Reporting) CIK: 0001779458 (see all company filings)

Type: 144